-
Je něco špatně v tomto záznamu ?
Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature
J. Žatecký, O. Coufal, P. Fabian, M. Holánek, E. Sehnálková, P. Burkoň
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
PubMed
37900556
DOI
10.1159/000530934
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Primary breast sarcoma is a very rare malignant type of breast tumours with an incidence of 0.1% of all primary breast malignancies. METHODS: We present a retrospective analysis of the case series from two hospitals in the Czech Republic with a review of the diagnostic and treatment approach to primary breast sarcomas with an analysis of published prognostic factors. RESULTS: Eleven patients were included in the study, 9 women and 2 men. Statistical evaluation revealed that tumour size (p = 0.1964), grade (p = 0.1667), margin distance (p = 0.5403), mitotic activity (p = 0.8577), or age (p = 0.7822) were not prognostic factors in our cohort. CONCLUSION: The analysis did not prove any of the factors, such as age, tumour size, grade, or mitotic activity, to be statistically significant prognostic factors. Based on the literature review, the most common published prognostic factors are tumour size, margin status, and grade, but the results are ambiguous.
Department of Comprehensive Cancer Care Faculty of Medicine Masaryk University Brno Czech Republic
Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Pathology Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Pathology Silesian Hospital in Opava Opava Czech Republic
Department of Radiation Oncology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Radiation Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Surgery Silesian Hospital in Opava Opava Czech Republic
Department of Surgical Oncology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Surgical Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022868
- 003
- CZ-PrNML
- 005
- 20240116163152.0
- 007
- ta
- 008
- 240105s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000530934 $2 doi
- 035 __
- $a (PubMed)37900556
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Žatecký, Jan $u Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Surgery, Silesian Hospital in Opava, Opava, Czech Republic $u The Institute of Paramedical Health Studies, Faculty of Public Policies, Silesian University, Opava, Czech Republic
- 245 10
- $a Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature / $c J. Žatecký, O. Coufal, P. Fabian, M. Holánek, E. Sehnálková, P. Burkoň
- 520 9_
- $a INTRODUCTION: Primary breast sarcoma is a very rare malignant type of breast tumours with an incidence of 0.1% of all primary breast malignancies. METHODS: We present a retrospective analysis of the case series from two hospitals in the Czech Republic with a review of the diagnostic and treatment approach to primary breast sarcomas with an analysis of published prognostic factors. RESULTS: Eleven patients were included in the study, 9 women and 2 men. Statistical evaluation revealed that tumour size (p = 0.1964), grade (p = 0.1667), margin distance (p = 0.5403), mitotic activity (p = 0.8577), or age (p = 0.7822) were not prognostic factors in our cohort. CONCLUSION: The analysis did not prove any of the factors, such as age, tumour size, grade, or mitotic activity, to be statistically significant prognostic factors. Based on the literature review, the most common published prognostic factors are tumour size, margin status, and grade, but the results are ambiguous.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Coufal, Oldřich $u Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Surgical Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Fabian, Pavel $u Department of Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Holánek, Miloš $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Sehnálková, Eva $u The Institute of Paramedical Health Studies, Faculty of Public Policies, Silesian University, Opava, Czech Republic $u Department of Pathology, Silesian Hospital in Opava, Opava, Czech Republic
- 700 1_
- $a Burkoň, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00173016 $t Breast care (Basel, Switzerland) $x 1661-3791 $g Roč. 18, č. 4 (2023), s. 262-269
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37900556 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240105 $b ABA008
- 991 __
- $a 20240116163149 $b ABA008
- 999 __
- $a ok $b bmc $g 2036429 $s 1209313
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 18 $c 4 $d 262-269 $e 20230512 $i 1661-3791 $m Breast care $n Breast Care (Basel) $x MED00173016
- LZP __
- $a Pubmed-20240105